Literature DB >> 3583074

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease.

F T de Dombal, A Softley.   

Abstract

Observer variation in calculating various indices for estimating the severity and activity of Crohn's disease is reported. Seven prospective users of Crohn's disease activity indices were presented with 10 'cases histories' compiled from relevant patient data and asked to calculate (independently) various indices of severity and activity from this information. The results showed a disquieting degree of observer variation in all indices studied. Similar results were obtained when 15 members of the International Organisation for the Study of Inflammatory Bowel Disease (IOIBD) reviewed one case history and also when members independently reviewed a series of real life cases. It is suggested that each index so far proposed is open to considerable observer variation, which casts some doubt upon the validity of studies so far carried out. Clarification of indices and the use of ranking methods can, however, do much to overcome this discrepancy.

Entities:  

Mesh:

Year:  1987        PMID: 3583074      PMCID: PMC1432811          DOI: 10.1136/gut.28.4.474

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Observations on the probability of error in medical diagnosis.

Authors:  G L SAIGER
Journal:  Ann Intern Med       Date:  1962-06       Impact factor: 25.391

2.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

3.  National Cooperative Crohn's Disease Study: study design and conduct of the study.

Authors:  D H Winship; R W Summers; J W Singleton; W R Best; J M Becktel; L F Lenk; F Kern
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases.

Authors:  J Myren; I A Bouchier; G Watkinson; A Softley; S E Clamp; F T de Dombal
Journal:  Scand J Gastroenterol Suppl       Date:  1984

6.  An index of inflammatory activity in patients with Crohn's disease.

Authors:  P A van Hees; P H van Elteren; H J van Lier; J H van Tongeren
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

  6 in total
  34 in total

1.  Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials.

Authors:  M Rothman; C Farup; W Stewart; L Helbers; J Zeldis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 2.  Psoas abscess complicating Crohn's disease: report of a case.

Authors:  M Ogihara; T Masaki; T Watanabe; K Hatano; K Matsuda; N Yahagi; M Ichinose; A Seichi; T Muto
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 3.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 4.  Assessing disease activity and disease activity indices for inflammatory bowel disease.

Authors:  Feng Xiao Li; Lloyd R Sutherland
Journal:  Curr Gastroenterol Rep       Date:  2002-12

5.  Effects of family history on inflammatory bowel disease characteristics in Japanese patients.

Authors:  Erika Kuwahara; Keiko Asakura; Yuji Nishiwaki; Nagamu Inoue; Mamoru Watanabe; Toshifumi Hibi; Toru Takebayashi
Journal:  J Gastroenterol       Date:  2012-03-01       Impact factor: 7.527

6.  Use of the Crohn's disease activity index in clinical trials of biological agents.

Authors:  Hugh-J Freeman
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

7.  Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.

Authors:  R H Resnick; H Royal; W Marshall; R Barron; T Werth
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

8.  Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.

Authors:  Shingo Kato; Mitsuko Ochiai; Tomoya Sakurada; Shino Ohno; Kyoko Miyamoto; Mina Sagara; Masataka Ito; Kyoko Takeuchi; Junko Imaki; Kazuro Itoh; Koji Yakabi
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

9.  Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Authors:  J Y Mary; R Modigliani
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

10.  Circulating cytokines reflect mucosal inflammatory status in patients with Crohn's disease.

Authors:  Farid Ljuca; Adnan Gegic; Nermin N Salkic; Nada Pavlovic-Calic
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.